| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |